13.44
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Dentsply Sirona Inc stock is traded at $13.44, with a volume of 5.71M.
It is up +1.05% in the last 24 hours and up +7.18% over the past month.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
See More
Previous Close:
$13.30
Open:
$13.81
24h Volume:
5.71M
Relative Volume:
1.30
Market Cap:
$2.68B
Revenue:
$3.90B
Net Income/Loss:
$-413.00M
P/E Ratio:
-6.4928
EPS:
-2.07
Net Cash Flow:
$365.00M
1W Performance:
+5.00%
1M Performance:
+7.18%
6M Performance:
-6.21%
1Y Performance:
-13.79%
Dentsply Sirona Inc Stock (XRAY) Company Profile
Name
Dentsply Sirona Inc
Sector
Industry
Phone
844-546-3722
Address
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
XRAY
Dentsply Sirona Inc
|
13.44 | 2.65B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
501.18 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.49 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
84.27 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.05 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
42.88 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-09-25 | Initiated | Barclays | Underweight |
| Nov-07-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-15-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-13-25 | Downgrade | Needham | Buy → Hold |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-23-25 | Downgrade | Jefferies | Buy → Hold |
| Jan-07-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-25-24 | Reiterated | Needham | Buy |
| Aug-20-24 | Reiterated | Needham | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Nov-16-23 | Initiated | Needham | Buy |
| Nov-10-23 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jan-12-23 | Upgrade | William Blair | Underperform → Mkt Perform |
| Aug-05-22 | Downgrade | William Blair | Mkt Perform → Underperform |
| Jun-02-22 | Upgrade | UBS | Neutral → Buy |
| Apr-20-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-20-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-19-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-19-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-31-22 | Initiated | Morgan Stanley | Overweight |
| Oct-01-21 | Resumed | Credit Suisse | Outperform |
| Aug-09-21 | Reiterated | H.C. Wainwright | Neutral |
| Aug-06-21 | Reiterated | Barrington Research | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Mar-02-21 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Mar-02-21 | Reiterated | H.C. Wainwright | Neutral |
| Jan-05-21 | Reiterated | H.C. Wainwright | Neutral |
| Dec-18-20 | Downgrade | Stifel | Buy → Hold |
| Nov-17-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Nov-09-20 | Reiterated | H.C. Wainwright | Neutral |
| Oct-22-20 | Upgrade | Guggenheim | Neutral → Buy |
| Aug-10-20 | Reiterated | H.C. Wainwright | Neutral |
| Jun-16-20 | Initiated | Piper Sandler | Overweight |
| Jun-15-20 | Reiterated | H.C. Wainwright | Neutral |
| May-27-20 | Upgrade | Evercore ISI | In-line → Outperform |
| May-11-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-24-20 | Reiterated | H.C. Wainwright | Neutral |
| Apr-08-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-07-20 | Downgrade | Goldman | Buy → Neutral |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Mar-03-20 | Reiterated | H.C. Wainwright | Neutral |
| Feb-19-20 | Reiterated | Stifel | Buy |
| Dec-11-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-02-19 | Upgrade | Wellington Shields | Hold → Gradually Accumulate |
| Jul-26-19 | Initiated | Evercore ISI | In-line |
| Jul-09-19 | Reiterated | H.C. Wainwright | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
View All
Dentsply Sirona Inc Stock (XRAY) Latest News
DENTSPLY SIRONA Inc. $XRAY Shares Acquired by Skba Capital Management LLC - MarketBeat
Zacks Research Upgrades DENTSPLY SIRONA (NASDAQ:XRAY) to Hold - MarketBeat
Dentsply Sirona (XRAY -7.1%): Geopolitical Shock Rattles Markets - Trefis
Insider Buying: DENTSPLY SIRONA (NASDAQ:XRAY) Director Acquires 22,445 Shares of Stock - MarketBeat
Insider Buying: DENTSPLY SIRONA (NASDAQ:XRAY) Director Acquires $392,383.20 in Stock - MarketBeat
Trust linked to DENTSPLY SIRONA (XRAY) director reports 50,000-share buy - Stock Titan
Insider Buying: James Forbes Acquires Shares of Dentsply Sirona Inc (XRAY) - GuruFocus
DENTSPLY SIRONA (XRAY) SVP receives 9,599-share stock award in Form 4 - Stock Titan
Dentsply Sirona (XRAY) SVP awarded 8,861 common shares in Form 4 - Stock Titan
Director James D. Forbes buys 5,000 DENTSPLY SIRONA (XRAY) shares in market trade - Stock Titan
Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2026 - Bitget
DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating a Challenging Landscape with Insights into Valuation and Dividend Potential - DirectorsTalk Interviews
Don't Overlook Dentsply (XRAY) International Revenue Trends While Assessing the Stock - Nasdaq
XRAY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Dentsply Compules Tips Aazon.co: Dentsply Sirona 642220 TPH Spectra ST Low Viscosity Spectrum Dental - hotelier.com.py
Dentsply Sirona, Burkhart expand distribution partnership - DrBicuspid.com
Intech Investment Management Buys $3.4M Stake in DENTSPLY SIRONA - National Today
Mizuho raises Dentsply Sirona stock price target on restructuring By Investing.com - Investing.com UK
DENTSPLY SIRONA (XRAY) director Brian McKeon files initial Form 3 - Stock Titan
Director James D. Forbes files initial Form 3 at DENTSPLY SIRONA (XRAY) - Stock Titan
UBS Adjusts DENTSPLY SIRONA Price Target to $18 From $16, Maintains Buy Rating - marketscreener.com
XRAY Analyst Rating: Barrington Research Raises Price Target to $17.00 | XRAY Stock News - GuruFocus
Barrington Adjusts Price Target on DENTSPLY SIRONA to $17 From $14, Maintains Outperform Rating - marketscreener.com
XRAY: Mizuho Maintains Neutral Rating and Raises Price Target | - GuruFocus
Dentsply Sirona stock slips in premarket as Mizuho hikes target to $16 - TechStock²
DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Raised to $17.00 at Barrington Research - MarketBeat
Mizuho Forecasts Strong Price Appreciation for DENTSPLY SIRONA (NASDAQ:XRAY) Stock - MarketBeat
Mizuho raises Dentsply Sirona stock price target on restructuring - Investing.com
265,978 Shares in DENTSPLY SIRONA Inc. $XRAY Bought by Intech Investment Management LLC - MarketBeat
DENTSPLY SIRONA Stock Surges 16% on Radical Restructuring: Here’s Where the Stock Could Be Headed in 2026 - TIKR.com
Dentsply Sirona Restructures and Broadens Partnerships, Targeting Cost Savings and Growth - StocksToTrade
Dentsply Sirona’s Restructuring to Yield Substantial Cost Savings - timothysykes.com
Vanguard Group Inc. Raises Stake in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
A Look At Dentsply Sirona (XRAY) Valuation After Q4 Beat And 24‑Month Turnaround Plan - Sahm
Dentsply Sirona (XRAY) Q4 Results: Revenue Exceeds Forecasts, Shares JumpNews and Statistics - IndexBox
Dentsply Sirona Boosts Market Confidence with Strategic Moves - StocksToTrade
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Q4 2025 Earnings Call Transcript - Insider Monkey
Dentsply Sirona Restructures Amid Partnership Expansion and Upgraded Ratings - timothysykes.com
Dentsply (XRAY) Rebounds 15.5% on Share Buyback - Yahoo Finance
Dentsply (+15%): Restructuring Overlooks Weak Guidance in Squeeze - Trefis
Why Are Dentsply Sirona (XRAY) Shares Soaring Today - The Globe and Mail
Dentsply Sirona Q4 2025 Results: Revenue Tops Forecasts, 2026 Guidance CautiousNews and Statistics - IndexBox
DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
DENTSPLY SIRONA Q4 Earnings Call Highlights - Yahoo Finance
Does Dividend Elimination And R&D Pivot Change The Bull Case For DENTSPLY SIRONA (XRAY)? - Yahoo Finance
DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price Up 13.3% After Analyst Upgrade - MarketBeat
Dentsply Sirona (XRAY): Baird Raises Price Target Amidst Neutral Rating | XRAY Stock News - GuruFocus
XRAY Stock Gains Despite Q4 Earnings Miss on Restructuring Initiative - TradingView
DENTSPLY SIRONA (XRAY) Reports Q4 Revenue Growth Despite Challen - GuruFocus
DENTSPLY SIRONA (NASDAQ:XRAY) Given New $14.00 Price Target at Robert W. Baird - MarketBeat
DENTSPLY SIRONA Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Dentsply Sirona Inc Stock (XRAY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):